arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Voyager Therapeutics, Inc.

VYGR

$3.27 ▲ +0.16 (+5.14%) at close

13 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Voyager Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $191.9M

Dividend Yield —

Revenue Growth -49.5% ↗

Op. Margin -326.6% ↘

ROIC -67.3% ↘

FCF / Share $-2.30 ↘

Trailing P/E —

Price / Book 1.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$40.37M

↓ -49.5% —

Net Income Profit after all expenses

$-119.72M

↓ -84.2% —

Operating Margin Operating profit as % of sales

-326.6%

↓ -213.7% 0th

FCF / Share Free cash flow per share

$-2.30

↓ -604.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2014

$0.00

FY 2015

$0.00

FY 2016

FY 2017

$0.00

FY 2018

FY 2019

$0.00

FY 2020

$0.00

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	-49.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-719%)	-68.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-950%)	511.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6290%)	9.3% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17%)	-78.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1077%)	63.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+699%)	1270.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15777%)	-24.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-410%)	-28.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-459%)	-18.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-325%)	—	—	—
EPS Growth YoY (%)	-80.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	36.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-84.2% Weak Weak Year-over-year change in net income	N/M	N/M	34.8% Excellent Excellent Year-over-year change in net income	N/M	N/M	50.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-24.9% Weak ↑ Weak Improving Year-over-year change in net income	-75.9% Weak ↓ Weak Declining Year-over-year change in net income	-35.5% Weak Weak Year-over-year change in net income	-81.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-604.7% Weak Weak Year-over-year change in free cash flow	N/M	N/M	73.3% Excellent Excellent Year-over-year change in free cash flow	50.1% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-0.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	28.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	13.5% Good ↓ Good Declining Compound annual revenue growth over 3 years	-26.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	70.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	156.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	94.4% Excellent Excellent Compound annual revenue growth over 3 years	-24.0% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	-25.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-5.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	101.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	32.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.3% Excellent Excellent Compound annual revenue growth over 5 years	58.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	46.0% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	-326.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2277%)	-104.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-794%)	48.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+225%)	-124.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-928%)	-196.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1412%)	16.0% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+7%)	-49.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-430%)	—	—	-290.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2036%)	-116.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-879%)	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-296.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2571%)	-81.3% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-777%)	52.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+341%)	-113.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1045%)	-190.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1686%)	21.5% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+79%)	-41.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-448%)	—	—	-282.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2455%)	-171.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1526%)	—	—
FCF Margin (%) (%)	-334.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-23.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	29.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-36.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-147.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-63.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	39.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-265.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-334.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-2.96x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.94x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	-67.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	51.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-86.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	14.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-195.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	54.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-52.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	34.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-31.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	10.5% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-125.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-61.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-507%)	-21.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	56.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+273%)	-78.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	-74.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-599%)	23.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+59%)	-43.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-392%)	-190.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1367%)	-52.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-452%)	-29.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	-17.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	78.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+422%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-2.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-65.30M	$-71.37M	$-68.80M	$-98.96M	$-117.43M	$-104.44M	$-86.04M	$-46.86M	$-31.53M	$-36.64M	$-31.31M	$-7.04M	$-135.00K

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$0.69	$1.39	$5.81	$1.07	$0.99	$4.61	$2.91	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-2.04	$-1.13	$3.08	$-1.21	$-1.89	$0.99	$-1.21	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.30	$-0.33	$1.74	$-0.39	$-1.46	$-2.93	$1.14	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	—	$0.00	$0.00	—	$0.00	—	$0.00	$0.00	—	—
Book Value per Share (USD)	$3.32	$5.48	$5.37	$1.53	$2.51	$4.13	$2.70	$1.44	$4.25	$5.31	$6.78	$-25.56	—
Tangible Book Value per Share (USD)	$3.32	$5.48	$5.37	$1.53	$2.51	$4.13	$2.70	$1.44	$4.25	$5.31	$6.78	$-25.56	—
Basic Weighted Avg Shares (shares)	58.69M	57.67M	43.02M	38.36M	37.67M	37.13M	35.90M	—	—	—	—	—	—
Dividend Payout Ratio (%)	—	—	—	—	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$176.15M	$227.02M	$255.18M	$51.91M	$85.72M	$171.00M	$228.65M	$130.81M	$155.89M	$164.98M	$171.96M	$5.88M	—
Total Equity (USD)	$196.08M	$299.76M	$236.32M	$59.02M	$95.06M	$154.32M	$99.51M	$46.45M	$134.05M	$135.92M	$169.07M	$-20.83M	$-3.83M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$40.37M	$80.00M	$250.01M	$40.91M	$37.41M	$171.13M	$104.39M	$7.62M	$10.13M	$14.22M	$17.33M	—	—
Depreciation Expense (USD)	$4.06M	$4.73M	$4.44M	$6.19M	$5.17M	$3.82M	$2.77M	$2.12M	$1.59M	$612.00K	$600.00K	$184.00K	—
Net Income, GAAP (USD)	$-119.72M	$-65.00M	$132.33M	$-46.41M	$-71.20M	$36.74M	$-43.60M	$-88.29M	$-70.70M	$-40.19M	$-29.67M	$-16.32M	—
Operating Cash Flow (USD)	$-132.47M	$-15.31M	$77.92M	$-12.51M	$-53.52M	$-96.72M	$48.67M	$-15.89M	$-61.35M	$-42.48M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 49 quarters

Voyager Therapeutics, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VYGR with peers